A blood test screens for over 50 cancer types by analyzing circulating tumor DNA, RNA, and methylation patterns. The test detects early signals across many cancers, including breast cancer, though most clinical practices don't yet offer it.
Most practices don't offer this in this method, but this makes a big difference. So imagine using a blood based multi cancer early detection. That means you just draw simple blood and you get 50 plus cancers. You can look at CTDNA, RNA, of course, breast cancers in there, methylation patterns. And this is so important because you're not just screening for breast cancer, but if breast cancer is there, we will start to see the early signals.
